NASDAQ$SRTA

Strata Critical Medical Inc · Q3 2021 earnings

Q3 2021 earnings · · Investor relations

Headline financials

Total Revenue

$13M

No prior period
EPS (adj)

-$0.15

No prior period
Capital Expenditures

-$230K

No prior period
Free Cash Flow

-$10.1M

No prior period
Net Income

-$24.3M

No prior period
Operating Income

-$7.77M

No prior period
Gross Profit

$3.04M

No prior period
Cash & Equivalents

$30M

No prior period
Total Assets

$346M

No prior period
Stock-Based Comp

$4.42M

No prior period

Revenue & EPS history

Strata Critical Medical · Revenue · Quarterly

$13M

Q3 2021
Beat estimate in 9 of 10 quarters(90%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2021

Historical avgQ3 2021

+3.4%

Avg return

Earnings day

+2.8%

Avg return

5 days after

+5.7%

Avg return

30 days after

54%

13 / 24 earnings

Positive

+38.8%

Q3 2023

Best reaction

-32.1%

Q4 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+10.6%+17.2%+19.7%
Q4 2025+6.9%+1.1%-7.6%
Q3 2025+9.5%+8.1%+4.3%
Q1 2025+18.7%+20.5%+41.4%
Q4 2024+7.1%+8.1%-4.9%
Q3 2024-4.4%-17.5%+8.9%
Q2 2024+17.3%+3.6%+2.9%
Q1 2024-3.3%-3.3%-16.0%
Q4 2023-32.1%-32.3%-3.5%
Q3 2023+38.8%+44.5%+44.5%
Q2 2023-7.9%-6.7%-24.3%
Q1 2023+9.4%+2.8%+28.1%
Q4 2022-9.7%-22.3%-32.0%
Q3 2022-2.3%-0.2%+3.4%
Q2 2022+8.0%+6.9%-17.5%
Q1 2022-15.0%+0.9%-2.3%
Q4 2021-3.2%+5.2%-2.0%
Q3 2021+0.3%+2.1%+41.4%
Q2 2021+18.0%+16.4%+58.7%
Q1 2021+13.7%+11.8%-11.8%
Q4 2020-0.1%-0.1%+3.1%
Q2 2020+0.0%-0.2%-0.1%
Q1 2020+1.0%+1.0%+1.3%
Q4 2019-0.2%-0.3%+0.7%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro